Jj. Hong et al., HIGH-DOSE-RATE VAGINAL BRACHYTHERAPY IN EARLY-STAGE ENDOMETRIAL CARCINOMA - PRELIMINARY-ANALYSIS, American journal of clinical oncology, 20(3), 1997, pp. 254-258
From 1987 to 1993, 69 women diagnosed with FIGO stages I and II carcin
oma of the endometrium underwent postoperative adjuvant irradiation (R
T) under protocol with high dose rate (HDR) afterloading vaginal apex
brachytherapy. All patients initially underwent total abdominal hyster
ectomy and bilateral salpingo-oopherectomy. Forty-four women received
HDR brachytherapy alone and 25 received external beam RT as well as HD
R brachytherapy. The median follow-up was 45 months. The 5-year diseas
e-free survival was 92% and the overall survival rate was 79%. Multiva
riate Cox regression analysis revealed that grade, age, and stage were
significant predictors of survival. The overall acute and late side e
ffects were minimal. It appears that HDR vaginal brachytherapy is comp
arable to the traditional low dose rate brachytherapy in prevention of
vaginal recurrence in endometrial carcinoma and should be considered
an effective treatment option.